Takeaways
#- The hosts interpreted Uber’s rapid recovery of broken support as a failed breakdown that could lead back toward its highs.
- Uber’s $85–$91 target range combined Fibonacci measurements using intraday extremes and closing prices.
- SharkNinja had a breakout test around $92 and an alternative risk reference around $87 near the gap low.
- AstraZeneca’s approach to $86.50 made a new entry less appealing even though its trend and momentum remained strong.
Uber (UBER) had briefly broken important support, then recovered it within days. Patrick Dunuwila and Sam Gatlin thought that reversal could carry the stock back toward its highs and beyond.
In the August 22, 2024 Chart Request Live, the pair kept returning to the difference between a strong chart and a useful entry. Uber’s failed breakdown offered a reason to expect further buying. SharkNinja (SN) had a compact pattern with nearby levels to watch. AstraZeneca (AZN), despite its strong uptrend, was already approaching an area where they would consider taking profits.
Uber had caught the breakdown traders off guard
Dunuwila described a brief move beneath key levels followed by a rapid recovery. In his interpretation, that could leave short sellers looking to cover and former holders considering whether to re-enter. The stock had invalidated the breakdown they had acted on.
Gatlin expected a move back toward the former highs, potentially through them. Dunuwila agreed that the recovery had more room to run. He placed the next target region around $85–$91.
That range came from two versions of the same Fibonacci calculation. One measured the prior move using intraday extremes; the other used closing prices. Dunuwila kept both results instead of presenting a single price as exact.
They emphasized that the method supplied a general area in which to reassess the position. Gatlin called Fibonacci analysis imperfect, and Dunuwila said the aim was to be in the right neighborhood rather than predict the turning point to the penny.
SharkNinja had a nearby test of the pattern
SharkNinja’s recent advance had tightened into what they described as a high-and-tight flag. A break above $92 would help confirm an upside resolution.
They also discussed a more immediate entry with an exit reference around $87, near the bottom of the gap. If the stock began filling that gap, the setup would be moving against the buyer. Those were two different ways to approach the chart: wait for the upper boundary to break, or use the nearby lower boundary to manage an earlier entry.
A Fibonacci extension put one target at approximately $98.87. Measuring the preceding advance produced a larger potential move, which brought the discussion to what traders call a $100 roll: a stock reaching a major round number for the first time and continuing beyond it.
They described that behavior as an observation, not a rule. Neither treated a touch of $100 as a promise of another fixed amount of upside.
AstraZeneca was strong, but closer to a selling decision
AstraZeneca had broken out of a roughly year-long base, retested the breakout and advanced toward $86.50. The hosts liked the trend and the momentum confirmation. Its relative strength index was making new highs with price, without the bearish divergence that might undermine the move.
The entry question was less attractive. After the recent advance, they would rather consider selling some into the $86.50 area than start a fresh position there. A pause or consolidation could create a better opportunity to reassess.
They were also clear that reaching a target did not mean the uptrend had ended or that the stock had become a short. If AstraZeneca moved decisively through $86.50, the next Fibonacci reference was about $102.59. The chart could remain strong while the immediate decision shifted from buying a breakout to managing an advance that had already traveled toward its target.
Questions and answers
#Questions about the original 2024-08-22 episode.
Why did Uber’s brief breakdown interest the hosts?
The stock recovered key levels shortly after breaking them. Dunuwila thought that could draw in short covering and renewed purchases from investors who had exited during the decline.
What were the two SharkNinja entry approaches?
They discussed waiting for a break above $92 to confirm the flag, or entering earlier while using the gap low around $87 as a risk reference. A move into the gap would weaken that earlier-entry setup.
Why consider taking profits in AstraZeneca without shorting it?
The stock was nearing the $86.50 target after a strong advance. They regarded that as a place to manage gains or wait for consolidation, while recognizing that the trend could continue and that a break through the level would open a higher target.
Adapted by Stock Market TV Editorial from the original video. Source date: . Article published: .